Scientist handling cell culture flask in advanced laboratory

Advanced Cell Therapies From Discovery to Market

Cellevolve develops novel cell therapies to address unmet medical needs through advanced biomanufacturing and strategic partnerships.

Advanced Capabilities

Engineered for Therapeutic Impact

Cellevolve combines cutting-edge biomanufacturing with strategic partnerships to transform cell therapies from lab to clinic.

Biomanufacturing platform with cell culture bioreactor

Proprietary Biomanufacturing

Cellevolve's advanced manufacturing platforms enable scalable, reproducible production of cell therapies with consistent quality and reduced cost.

Cell therapy research and development workspace

Accelerated Development Pathway

From discovery through commercialization, Cellevolve streamlines the path to market with integrated expertise and established regulatory partnerships.

Academic researchers collaborating on cell therapy innovation

Strategic Academic Partnerships

Cellevolve collaborates with leading academic institutions to access cutting-edge research, validate approaches, and strengthen clinical evidence.

GMP-certified manufacturing control and monitoring systems

Regulatory-Ready Manufacturing

Cellevolve operates with GMP standards and regulatory expertise built in, reducing timelines and risk as therapies advance toward patient access.

Clinical research facility dedicated to unmet medical needs

Unmet Medical Need Focus

Cellevolve prioritizes therapies targeting conditions with limited treatment options, maximizing clinical impact and patient benefit.

Partnership collaboration on cell therapy commercialization

End-to-End Partnership Model

Cellevolve supports pharma and biotech partners at every stage, from technology transfer and manufacturing scale-up to market launch and beyond.

Trusted by leaders

Partners and patients believe in our mission

Cellevolve's cell therapies are advancing patient outcomes through partnerships with leading healthcare institutions and research organizations.

Cellevolve's manufacturing platform enabled us to move our therapy from the lab to clinical trials faster than we thought possible. Their expertise in biomanufacturing was invaluable.

Dr. James Martinez

Dr. James Martinez

Chief Scientific Officer, Academic Medical Center

Working with Cellevolve transformed how we approach cell therapy commercialization. Their collaborative approach and technical depth gave us confidence in our pathway to market.

Sarah Chen

Sarah Chen

VP of Business Development, Biotech Company

The team at Cellevolve understood our unmet medical needs and designed a therapy strategy tailored to our patient population. Their commitment to patient outcomes is genuine.

Dr. Michael Thompson

Dr. Michael Thompson

Medical Director, Hospital Network

Cellevolve's advanced biomanufacturing platforms reduced our production timelines by months. They're serious about accelerating patient access to cell therapies.

Dr. Aisha Patel

Dr. Aisha Patel

Director of Manufacturing, Regenerative Medicine Company

From discovery to commercialization, Cellevolve provided the expertise and infrastructure we needed. Their San Francisco team is truly dedicated to advancing cell therapy innovation.

Dr. Robert Kim

Dr. Robert Kim

Founder, Cell Therapy Start-up

Cellevolve's collaborative model with academic partners accelerates research impact. They bridge the gap between discovery and real-world application better than anyone we've worked with.

Dr. Elena Rodriguez

Dr. Elena Rodriguez

Professor of Cell Biology, Research University

Cellevolve achievements

Advancing cell therapy from discovery to market

Cellevolve accelerates novel treatments through advanced biomanufacturing and strategic partnerships. Our progress reflects our commitment to solving unmet medical needs.

5+

Active cell therapy programs

Cellevolve develops multiple therapeutic candidates addressing serious unmet medical needs.

15+

Academic and industry partners

Collaborations with leading institutions accelerate our path from discovery to commercialization.

3

Manufacturing platforms

Advanced biomanufacturing capabilities enable scalable production of cell therapies.

San Francisco

Based in innovation hub

Operating from San Francisco, California, Cellevolve connects research with real-world patient impact.

Service offerings

Flexible engagement models for your cell therapy needs

Cellevolve offers tiered service packages designed to support partners at every stage, from early research through commercial manufacturing.

Research & Development

Custom

project-based

Foundational cell therapy development with advanced biomanufacturing platform access and technical support.

Request details

Features:

Platform access
Process optimization
Technical consultation
Milestone reporting
Most common

Commercialization

Custom

contract-based

End-to-end support scaling cell therapies from development into clinical and commercial production.

Discuss partnership

Features:

Manufacturing scale-up
Regulatory guidance
Quality assurance
Supply chain support

Manufacturing Services

Custom

volume-based

Dedicated biomanufacturing capacity for proven cell therapy candidates with full GMP compliance.

Explore capacity

Features:

GMP production
Quality control
Batch documentation
Scalable volumes

Academic Partnerships

Custom

collaborative

Accelerated discovery and validation programs for academic institutions driving cell therapy innovation.

Connect with us

Features:

Shared platform access
Co-development terms
Publication support
Funding guidance
QUESTIONS

Common questions about our cell therapies

Find answers about Cellevolve's services, partnerships, and cell therapy development process.

What cell therapies does Cellevolve develop?

Cellevolve develops novel cell therapies designed to address unmet medical needs. Our advanced biomanufacturing platforms enable us to create cutting-edge treatments. We work with academic and industry partners to move therapies from discovery through commercialization.

How does Cellevolve accelerate therapy development?

We combine proprietary biomanufacturing technology with strategic partnerships to shorten time-to-market. Our platform supports research and development, scale-up, and manufacturing. This integrated approach helps therapies reach patients faster.

Who does Cellevolve partner with?

Cellevolve collaborates with leading academic institutions and industry partners to strengthen therapy development. These partnerships bring expertise, resources, and validation to advance our programs. We're open to new partnerships that align with our mission.

What services does Cellevolve offer partners?

We provide research support, manufacturing expertise, commercialization guidance, and technology licensing. Our team helps partners navigate cell therapy development from early stage through market launch. Contact us to discuss how we can support your program.

Where is Cellevolve based?

Cellevolve is headquartered in San Francisco, California. Our location in the Bay Area connects us with leading research institutions, biotech talent, and industry partners driving innovation in cell therapy.

How can I learn more about working with Cellevolve?

Reach out to our team to discuss partnership opportunities, investment, or collaboration. We're available to answer questions about our therapies, services, and vision for advancing patient outcomes in cell therapy.

Ready to explore partnership opportunities?

Contact our team to discuss how Cellevolve can advance your cell therapy program.

Scientist handling a cell therapy sample vial in a modern laboratory

Let's transform discovery into patient impact.

Connect with our team to explore partnerships, licensing opportunities, or investment in the next generation of cell therapies.